FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2913690639> ?p ?o ?g. }

• W2913690639 endingPage "264" @default.
• W2913690639 startingPage "258" @default.
• W2913690639 abstract "Abstract Background: There is preliminary evidence linking physical activity to better prostate cancer outcomes, though the molecular mechanisms underlying this association are not clear. Methods: In a Seattle-based cohort of patients diagnosed with clinically localized prostate cancer and prospective follow-up for outcomes (n = 1,354), we studied the association between self-reported vigorous physical activity and prostate cancer progression to a metastatic–lethal phenotype. A subset of patients had prostate cancer tissue samples available for investigating DNA methylation (Infinium HumanMethylation450 BeadChip array) and exercise (n = 524). Results: Patients who had vigorous physical activity at least once per week during the year before diagnosis (∼79% of the cohort) were significantly less likely to progress to metastatic–lethal prostate cancer compared with those who had vigorous physical activity less frequently (adjusted hazard ratio = 0.63; P = 0.029). Among the subset of men who had radical prostatectomy as primary treatment and tumor tissue available, a differentially methylated region (DMR) was identified (family-wise error rate = 0.03, hypomethylated in the weekly exercise group), with 9 methylation probes located in the promoter region of CRACR2A. This gene encodes a calcium binding protein involved in innate immune response. The methylation level of the nine CpGs was inversely correlated with CRACR2A gene expression (average correlation coefficient = –0.35). Conclusions: Vigorous physical activity before diagnosis is associated with epigenetic alterations of CRACR2A and prostate cancer metastatic–lethal progression. Impact: This analysis provides strong evidence for the association between vigorous physical activity and a less likelihood to develop metastatic–lethal progression, and a suggestive link between exercise and DNA methylation in the CRACRA2A gene." @default.
• W2913690639 created "2019-02-21" @default.
• W2913690639 creator A5016200723 @default.
• W2913690639 creator A5024792434 @default.
• W2913690639 creator A5032281064 @default.
• W2913690639 creator A5054491363 @default.
• W2913690639 creator A5056168495 @default.
• W2913690639 creator A5067643723 @default.
• W2913690639 creator A5080866168 @default.
• W2913690639 date "2019-02-01" @default.
• W2913690639 modified "2023-10-17" @default.
• W2913690639 title "Vigorous Physical Activity Is Associated with Lower Risk of Metastatic–Lethal Progression in Prostate Cancer and Hypomethylation in the <i>CRACR2A</i> Gene" @default.
• W2913690639 cites W1979266382 @default.
• W2913690639 cites W1985828044 @default.
• W2913690639 cites W1986531910 @default.
• W2913690639 cites W2003832336 @default.
• W2913690639 cites W2017502278 @default.
• W2913690639 cites W2020325237 @default.
• W2913690639 cites W2025179609 @default.
• W2913690639 cites W2044251727 @default.
• W2913690639 cites W2066746433 @default.
• W2913690639 cites W2077807460 @default.
• W2913690639 cites W2080922260 @default.
• W2913690639 cites W2081098333 @default.
• W2913690639 cites W2100578216 @default.
• W2913690639 cites W2102525336 @default.
• W2913690639 cites W2103115232 @default.
• W2913690639 cites W2107665951 @default.
• W2913690639 cites W2110724065 @default.
• W2913690639 cites W2128130893 @default.
• W2913690639 cites W2130752875 @default.
• W2913690639 cites W2135455143 @default.
• W2913690639 cites W2160769891 @default.
• W2913690639 cites W2161431826 @default.
• W2913690639 cites W2165246391 @default.
• W2913690639 cites W2165680481 @default.
• W2913690639 cites W2170552969 @default.
• W2913690639 cites W2465555849 @default.
• W2913690639 cites W2756016080 @default.
• W2913690639 doi "https://doi.org/10.1158/1055-9965.epi-18-0622" @default.
• W2913690639 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6363836" @default.
• W2913690639 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30464020" @default.
• W2913690639 hasPublicationYear "2019" @default.
• W2913690639 type Work @default.
• W2913690639 sameAs 2913690639 @default.
• W2913690639 citedByCount "20" @default.
• W2913690639 countsByYear W29136906392020 @default.
• W2913690639 countsByYear W29136906392021 @default.
• W2913690639 countsByYear W29136906392022 @default.
• W2913690639 crossrefType "journal-article" @default.
• W2913690639 hasAuthorship W2913690639A5016200723 @default.
• W2913690639 hasAuthorship W2913690639A5024792434 @default.
• W2913690639 hasAuthorship W2913690639A5032281064 @default.
• W2913690639 hasAuthorship W2913690639A5054491363 @default.
• W2913690639 hasAuthorship W2913690639A5056168495 @default.
• W2913690639 hasAuthorship W2913690639A5067643723 @default.
• W2913690639 hasAuthorship W2913690639A5080866168 @default.
• W2913690639 hasBestOaLocation W29136906391 @default.
• W2913690639 hasConcept C104317684 @default.
• W2913690639 hasConcept C121608353 @default.
• W2913690639 hasConcept C126322002 @default.
• W2913690639 hasConcept C143998085 @default.
• W2913690639 hasConcept C150194340 @default.
• W2913690639 hasConcept C188816634 @default.
• W2913690639 hasConcept C190727270 @default.
• W2913690639 hasConcept C207103383 @default.
• W2913690639 hasConcept C2776235491 @default.
• W2913690639 hasConcept C2779466945 @default.
• W2913690639 hasConcept C2780192828 @default.
• W2913690639 hasConcept C33288867 @default.
• W2913690639 hasConcept C41091548 @default.
• W2913690639 hasConcept C44249647 @default.
• W2913690639 hasConcept C54355233 @default.
• W2913690639 hasConcept C71924100 @default.
• W2913690639 hasConcept C72563966 @default.
• W2913690639 hasConcept C86803240 @default.
• W2913690639 hasConceptScore W2913690639C104317684 @default.
• W2913690639 hasConceptScore W2913690639C121608353 @default.
• W2913690639 hasConceptScore W2913690639C126322002 @default.
• W2913690639 hasConceptScore W2913690639C143998085 @default.
• W2913690639 hasConceptScore W2913690639C150194340 @default.
• W2913690639 hasConceptScore W2913690639C188816634 @default.
• W2913690639 hasConceptScore W2913690639C190727270 @default.
• W2913690639 hasConceptScore W2913690639C207103383 @default.
• W2913690639 hasConceptScore W2913690639C2776235491 @default.
• W2913690639 hasConceptScore W2913690639C2779466945 @default.
• W2913690639 hasConceptScore W2913690639C2780192828 @default.
• W2913690639 hasConceptScore W2913690639C33288867 @default.
• W2913690639 hasConceptScore W2913690639C41091548 @default.
• W2913690639 hasConceptScore W2913690639C44249647 @default.
• W2913690639 hasConceptScore W2913690639C54355233 @default.
• W2913690639 hasConceptScore W2913690639C71924100 @default.
• W2913690639 hasConceptScore W2913690639C72563966 @default.
• W2913690639 hasConceptScore W2913690639C86803240 @default.
• W2913690639 hasFunder F4320337351 @default.
• W2913690639 hasIssue "2" @default.
• W2913690639 hasLocation W29136906391 @default.
• W2913690639 hasLocation W29136906392 @default.

• next